Of all the leukemia cell lines analyzed, thirteen out of twenty-three carry a hypo-, hyper-, or near diploid karyotype, thus minimizing a TERRA dosage response in five myeloid and eight lymphoid leukemia, including four out of five MLL-r ALL. Here, KMT2A is linked to leukemia.